Viewing Study NCT05228132

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:24 PM
Ignite Modification Date: 2026-04-04 @ 6:59 AM
Study NCT ID: NCT05228132
Status: TERMINATED
Last Update Posted: 2024-04-11
First Post: 2022-01-27
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: The Pristine Post-Market Study
Sponsor: C. R. Bard
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Failure, Chronic View
None Hemodialysis Complication View
None Hemodialysis Catheter Infection View
None Hemodialysis Access Failure View
None Central Venous Catheter Related Bloodstream Infection View
None End Stage Renal Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Kidney Replacement Therapy View
None Hemodialysis View
None Vascular Access View